Home539871 • BOM
add
Thyrocare Technologies Ltd
Nakaraang pagsara
₹970.35
Sakop ng araw
₹945.60 - ₹975.90
Sakop ng taon
₹545.05 - ₹1,002.00
Market cap
50.65B INR
Average na Volume
6.71K
P/E ratio
61.01
Dividend yield
1.88%
Primary exchange
NSE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
(INR) | Set 2024info | Y/Y na pagbabago |
---|---|---|
Kita | 1.77B | 19.84% |
Gastos sa pagpapatakbo | 616.60M | 22.27% |
Net na kita | 266.70M | 31.12% |
Net profit margin | 15.04 | 9.46% |
Kita sa bawat share | 4.98 | — |
EBITDA | 474.35M | 27.82% |
Aktuwal na % ng binabayarang buwis | 28.15% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(INR) | Set 2024info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 1.38B | 38.47% |
Kabuuang asset | 5.97B | 0.74% |
Kabuuang sagutin | 1.08B | 3.20% |
Kabuuang equity | 4.89B | — |
Natitirang share | 53.45M | — |
Presyo para makapag-book | 10.62 | — |
Return on assets | — | — |
Return on capital | 16.35% | — |
Cash Flow
Net change in cash
(INR) | Set 2024info | Y/Y na pagbabago |
---|---|---|
Net na kita | 266.70M | 31.12% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Thyrocare Technologies Limited is an Indian multinational chain of diagnostic and preventive care laboratories, headquartered in Navi Mumbai. As of 2021, the company has a total of 1,122 outlets and collection centers across India and parts of Nepal, Bangladesh and the Middle East.
On 26 June 2021, Indian e-pharmacy and online healthcare aggregator PharmEasy's parent API Holdings acquired a 66.1% controlling stake in Thyrocare, making Thyrocare the first Indian listed company to be acquired by a startup. Wikipedia
Itinatag
1996
Headquarters
Website
Mga Empleyado
1,693